Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA.
Key Laboratory of RNA Innovation, Science and Engineering, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China.
Nat Biomed Eng. 2024 Nov;8(11):1412-1424. doi: 10.1038/s41551-024-01267-7. Epub 2024 Nov 22.
Ionizable lipids largely determine the biocompatibility of lipid nanoparticles (LNPs) and the efficacy for mRNA delivery. Rational design and combinatorial synthesis have led to the development of potent and biodegradable ionizable lipids, yet methodologies for the stepwise optimization of ionizable lipid structure are lacking. Here we show that iterative chemical derivatization and combinatorial chemistry, and in particular the amine-aldehyde-alkyne coupling reaction, can be leveraged to iteratively accelerate the structural optimization of propargylamine-based ionizable lipids (named A-lipids) to improve their delivery activity and biodegradability. Through five cycles of such directed chemical evolution, we identified dozens of biodegradable and asymmetric A-lipids with delivery activity comparable to or better than a benchmark ionizable lipid. We then derived structure-activity relationships for the headgroup, ester linkage and tail. Compared with standard ionizable lipids, the lead A-lipid improved the hepatic delivery of an mRNA-based genome editor and the intramuscular delivery of an mRNA vaccine against SARS-CoV-2. Structural criteria for ionizable lipids discovered via directed chemical evolution may accelerate the development of LNPs for mRNA delivery.
可离子化脂质在很大程度上决定了脂质纳米颗粒 (LNPs) 的生物相容性和 mRNA 递送的功效。合理的设计和组合合成已经导致了有效且可生物降解的可离子化脂质的发展,然而,对于可离子化脂质结构的逐步优化的方法学仍然缺乏。在这里,我们展示了迭代化学衍生和组合化学,特别是胺-醛-炔偶联反应,可以用于迭代加速基于炔丙胺的可离子化脂质(命名为 A-脂质)的结构优化,以提高其递送活性和生物降解性。通过五轮这样的定向化学进化,我们鉴定了数十种可生物降解和不对称的 A-脂质,其递送活性可与基准可离子化脂质媲美或优于基准可离子化脂质。然后,我们推导出了针对头部基团、酯键和尾部的结构-活性关系。与标准可离子化脂质相比,先导 A-脂质提高了基于 mRNA 的基因组编辑在肝脏中的递送效率和 SARS-CoV-2 mRNA 疫苗在肌肉中的递送效率。通过定向化学进化发现的可离子化脂质的结构标准可能会加速用于 mRNA 递送的 LNPs 的开发。